| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Concussion | 70 | 2026 | 244 | 14.340 |
Why?
|
| Brain Injuries | 90 | 2025 | 712 | 11.210 |
Why?
|
| Brain Injuries, Traumatic | 44 | 2026 | 315 | 9.230 |
Why?
|
| White Matter | 29 | 2025 | 231 | 6.860 |
Why?
|
| Military Personnel | 31 | 2026 | 215 | 6.430 |
Why?
|
| Neuroimaging | 30 | 2025 | 406 | 5.840 |
Why?
|
| Brain | 75 | 2026 | 3247 | 5.630 |
Why?
|
| Magnetic Resonance Imaging | 82 | 2026 | 3928 | 4.660 |
Why?
|
| Stress Disorders, Post-Traumatic | 33 | 2026 | 679 | 4.450 |
Why?
|
| Veterans | 43 | 2026 | 1801 | 4.340 |
Why?
|
| Diffusion Tensor Imaging | 38 | 2024 | 261 | 4.060 |
Why?
|
| Blast Injuries | 11 | 2024 | 58 | 2.610 |
Why?
|
| Low-Level Light Therapy | 4 | 2025 | 19 | 2.260 |
Why?
|
| Neuropsychological Tests | 54 | 2026 | 998 | 2.250 |
Why?
|
| Cognition Disorders | 26 | 2025 | 565 | 2.140 |
Why?
|
| Athletic Injuries | 12 | 2025 | 69 | 2.000 |
Why?
|
| Intimate Partner Violence | 6 | 2026 | 29 | 1.860 |
Why?
|
| Trauma Severity Indices | 13 | 2024 | 87 | 1.490 |
Why?
|
| Nerve Fibers, Myelinated | 12 | 2014 | 84 | 1.470 |
Why?
|
| Mental Disorders | 14 | 2025 | 909 | 1.460 |
Why?
|
| Humans | 225 | 2026 | 131967 | 1.430 |
Why?
|
| Adult | 96 | 2026 | 31734 | 1.390 |
Why?
|
| Cognition | 19 | 2026 | 845 | 1.370 |
Why?
|
| Cerebral Cortex | 9 | 2020 | 468 | 1.360 |
Why?
|
| Nerve Net | 4 | 2025 | 271 | 1.300 |
Why?
|
| Post-Concussion Syndrome | 11 | 2024 | 50 | 1.300 |
Why?
|
| Image Processing, Computer-Assisted | 23 | 2024 | 614 | 1.300 |
Why?
|
| Phantoms, Imaging | 4 | 2024 | 149 | 1.280 |
Why?
|
| Male | 145 | 2026 | 65357 | 1.260 |
Why?
|
| Memory Disorders | 8 | 2015 | 207 | 1.230 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 12 | 2024 | 182 | 1.220 |
Why?
|
| Female | 146 | 2026 | 71316 | 1.220 |
Why?
|
| Acceleration | 3 | 2025 | 24 | 1.220 |
Why?
|
| Adolescent | 97 | 2026 | 21008 | 1.190 |
Why?
|
| Anisotropy | 22 | 2023 | 124 | 1.140 |
Why?
|
| Neural Pathways | 10 | 2026 | 289 | 1.030 |
Why?
|
| Cerebellum | 4 | 2025 | 459 | 0.960 |
Why?
|
| Middle Aged | 61 | 2026 | 28911 | 0.950 |
Why?
|
| Temporal Lobe | 5 | 2016 | 116 | 0.950 |
Why?
|
| Corpus Callosum | 8 | 2021 | 107 | 0.940 |
Why?
|
| Executive Function | 7 | 2026 | 136 | 0.900 |
Why?
|
| Young Adult | 47 | 2026 | 10108 | 0.900 |
Why?
|
| Firefighters | 1 | 2025 | 35 | 0.860 |
Why?
|
| Neurologic Examination | 8 | 2018 | 197 | 0.840 |
Why?
|
| Longitudinal Studies | 24 | 2025 | 1519 | 0.840 |
Why?
|
| Soccer | 2 | 2024 | 8 | 0.820 |
Why?
|
| Child | 80 | 2026 | 26332 | 0.810 |
Why?
|
| Alcoholism | 2 | 2022 | 246 | 0.780 |
Why?
|
| Musculoskeletal System | 2 | 2021 | 18 | 0.750 |
Why?
|
| Brain Mapping | 13 | 2026 | 391 | 0.750 |
Why?
|
| Memory, Short-Term | 9 | 2022 | 141 | 0.740 |
Why?
|
| Craniocerebral Trauma | 4 | 2026 | 144 | 0.730 |
Why?
|
| Biomedical Research | 3 | 2025 | 558 | 0.730 |
Why?
|
| Memory | 9 | 2024 | 360 | 0.720 |
Why?
|
| Research Design | 6 | 2018 | 723 | 0.700 |
Why?
|
| Prefrontal Cortex | 5 | 2022 | 222 | 0.690 |
Why?
|
| Behavior | 2 | 2012 | 70 | 0.660 |
Why?
|
| Socialization | 1 | 2020 | 18 | 0.660 |
Why?
|
| Chronic Traumatic Encephalopathy | 2 | 2019 | 6 | 0.630 |
Why?
|
| Atrophy | 10 | 2023 | 251 | 0.620 |
Why?
|
| Basal Ganglia | 2 | 2012 | 60 | 0.600 |
Why?
|
| Gray Matter | 4 | 2025 | 55 | 0.600 |
Why?
|
| Image Interpretation, Computer-Assisted | 7 | 2024 | 241 | 0.600 |
Why?
|
| Control Groups | 1 | 2018 | 11 | 0.580 |
Why?
|
| Cohort Studies | 16 | 2024 | 5122 | 0.580 |
Why?
|
| Cross-Sectional Studies | 22 | 2026 | 3843 | 0.580 |
Why?
|
| Verbal Learning | 6 | 2024 | 69 | 0.550 |
Why?
|
| Recovery of Function | 9 | 2020 | 452 | 0.540 |
Why?
|
| Iraq War, 2003-2011 | 12 | 2022 | 126 | 0.500 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 113 | 0.500 |
Why?
|
| Unconsciousness | 1 | 2016 | 17 | 0.490 |
Why?
|
| United States | 25 | 2026 | 11827 | 0.480 |
Why?
|
| Boxing | 1 | 2015 | 4 | 0.480 |
Why?
|
| Glasgow Coma Scale | 13 | 2018 | 204 | 0.470 |
Why?
|
| Afghan Campaign 2001- | 11 | 2022 | 118 | 0.470 |
Why?
|
| Prospective Studies | 19 | 2026 | 6522 | 0.460 |
Why?
|
| Sports | 2 | 2025 | 64 | 0.450 |
Why?
|
| Biomarkers | 8 | 2026 | 3415 | 0.440 |
Why?
|
| Emotions | 3 | 2013 | 367 | 0.420 |
Why?
|
| Postural Balance | 4 | 2024 | 130 | 0.410 |
Why?
|
| Mental Processes | 1 | 2013 | 38 | 0.410 |
Why?
|
| Sex Offenses | 2 | 2025 | 52 | 0.410 |
Why?
|
| Cerebrum | 1 | 2013 | 34 | 0.410 |
Why?
|
| Brain Injury, Chronic | 3 | 2018 | 17 | 0.400 |
Why?
|
| Social Behavior | 5 | 2014 | 217 | 0.390 |
Why?
|
| Research Report | 1 | 2013 | 71 | 0.390 |
Why?
|
| Case-Control Studies | 14 | 2026 | 3453 | 0.390 |
Why?
|
| Pilot Projects | 7 | 2025 | 1457 | 0.390 |
Why?
|
| Organ Size | 6 | 2025 | 437 | 0.390 |
Why?
|
| Youth Sports | 2 | 2025 | 7 | 0.380 |
Why?
|
| Dominance, Cerebral | 3 | 2009 | 50 | 0.380 |
Why?
|
| Cognitive Dysfunction | 3 | 2022 | 355 | 0.370 |
Why?
|
| Gyrus Cinguli | 2 | 2013 | 134 | 0.370 |
Why?
|
| Affective Symptoms | 2 | 2013 | 64 | 0.360 |
Why?
|
| Child Development | 2 | 2018 | 274 | 0.360 |
Why?
|
| Reproducibility of Results | 11 | 2024 | 2992 | 0.350 |
Why?
|
| Frontal Lobe | 3 | 2010 | 116 | 0.350 |
Why?
|
| Perforant Pathway | 1 | 2011 | 9 | 0.350 |
Why?
|
| Hippocampus | 4 | 2021 | 805 | 0.340 |
Why?
|
| Amygdala | 2 | 2013 | 87 | 0.340 |
Why?
|
| Alzheimer Disease | 4 | 2022 | 876 | 0.330 |
Why?
|
| Angelman Syndrome | 1 | 2010 | 68 | 0.320 |
Why?
|
| Hypothermia, Induced | 3 | 2021 | 175 | 0.320 |
Why?
|
| Aging | 3 | 2024 | 1269 | 0.310 |
Why?
|
| Age Factors | 10 | 2024 | 2869 | 0.310 |
Why?
|
| Developmental Disabilities | 2 | 2013 | 771 | 0.310 |
Why?
|
| Nerve Fibers | 1 | 2010 | 69 | 0.310 |
Why?
|
| Connectome | 2 | 2025 | 126 | 0.310 |
Why?
|
| Aged | 22 | 2025 | 21279 | 0.300 |
Why?
|
| Brain Neoplasms | 3 | 2023 | 1300 | 0.300 |
Why?
|
| Exercise | 2 | 2025 | 866 | 0.300 |
Why?
|
| Athletes | 3 | 2024 | 72 | 0.290 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 3 | 2023 | 45 | 0.270 |
Why?
|
| Hypothermia | 2 | 2021 | 63 | 0.270 |
Why?
|
| Tomography, Emission-Computed | 2 | 2006 | 36 | 0.270 |
Why?
|
| Head Injuries, Closed | 1 | 2007 | 45 | 0.260 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2020 | 237 | 0.250 |
Why?
|
| Reperfusion Injury | 2 | 2021 | 109 | 0.250 |
Why?
|
| Amnesia, Retrograde | 1 | 2006 | 3 | 0.250 |
Why?
|
| Adaptation, Psychological | 5 | 2024 | 437 | 0.250 |
Why?
|
| Magnetoencephalography | 3 | 2023 | 41 | 0.250 |
Why?
|
| Analysis of Variance | 7 | 2014 | 955 | 0.250 |
Why?
|
| Functional Laterality | 6 | 2016 | 184 | 0.250 |
Why?
|
| Medical Audit | 1 | 2006 | 96 | 0.240 |
Why?
|
| Thalamic Nuclei | 1 | 2025 | 20 | 0.240 |
Why?
|
| Chronic Pain | 2 | 2018 | 164 | 0.230 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2018 | 397 | 0.230 |
Why?
|
| Semantics | 1 | 2025 | 26 | 0.230 |
Why?
|
| Pediatrics | 2 | 2012 | 1239 | 0.220 |
Why?
|
| Walking Speed | 1 | 2025 | 18 | 0.220 |
Why?
|
| Entorhinal Cortex | 1 | 2024 | 23 | 0.220 |
Why?
|
| Arachidonic Acid | 1 | 2024 | 54 | 0.220 |
Why?
|
| Apolipoprotein E4 | 1 | 2024 | 52 | 0.220 |
Why?
|
| Speech | 1 | 2025 | 70 | 0.210 |
Why?
|
| Writing | 1 | 2025 | 60 | 0.210 |
Why?
|
| Docosahexaenoic Acids | 1 | 2024 | 67 | 0.210 |
Why?
|
| MicroRNAs | 2 | 2022 | 895 | 0.210 |
Why?
|
| Algorithms | 3 | 2024 | 1686 | 0.210 |
Why?
|
| Neuroglia | 1 | 2026 | 223 | 0.210 |
Why?
|
| Problem Solving | 3 | 2010 | 65 | 0.210 |
Why?
|
| Statistics as Topic | 4 | 2016 | 244 | 0.210 |
Why?
|
| Sex Factors | 5 | 2025 | 1352 | 0.210 |
Why?
|
| Rest | 2 | 2024 | 63 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 1307 | 0.200 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2016 | 177 | 0.200 |
Why?
|
| Chronic Disease | 4 | 2019 | 1239 | 0.200 |
Why?
|
| Multiple Trauma | 1 | 2024 | 62 | 0.200 |
Why?
|
| Conduct Disorder | 1 | 2023 | 32 | 0.200 |
Why?
|
| Glasgow Outcome Scale | 4 | 2013 | 50 | 0.200 |
Why?
|
| Axons | 1 | 2006 | 384 | 0.200 |
Why?
|
| Terminology as Topic | 1 | 2025 | 227 | 0.200 |
Why?
|
| Prognosis | 6 | 2022 | 4961 | 0.190 |
Why?
|
| Walking | 1 | 2025 | 234 | 0.190 |
Why?
|
| Multicenter Studies as Topic | 2 | 2020 | 300 | 0.190 |
Why?
|
| Severity of Illness Index | 9 | 2022 | 3095 | 0.190 |
Why?
|
| Parietal Lobe | 2 | 2016 | 47 | 0.190 |
Why?
|
| Survivorship | 1 | 2022 | 46 | 0.180 |
Why?
|
| Mental Health | 1 | 2025 | 384 | 0.180 |
Why?
|
| Acute Disease | 4 | 2018 | 1153 | 0.180 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2021 | 12 | 0.180 |
Why?
|
| Football | 1 | 2021 | 36 | 0.170 |
Why?
|
| Follow-Up Studies | 8 | 2021 | 5298 | 0.170 |
Why?
|
| Frontotemporal Dementia | 1 | 2022 | 67 | 0.170 |
Why?
|
| Proton Therapy | 1 | 2022 | 157 | 0.170 |
Why?
|
| Theory of Mind | 2 | 2011 | 28 | 0.170 |
Why?
|
| Neuropsychology | 1 | 2021 | 24 | 0.170 |
Why?
|
| Risk Factors | 12 | 2025 | 10998 | 0.170 |
Why?
|
| Musculoskeletal Diseases | 3 | 2021 | 56 | 0.160 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 243 | 0.160 |
Why?
|
| Socioeconomic Factors | 4 | 2015 | 895 | 0.160 |
Why?
|
| Time Factors | 10 | 2021 | 6285 | 0.160 |
Why?
|
| tau Proteins | 2 | 2024 | 257 | 0.160 |
Why?
|
| Treatment Outcome | 10 | 2015 | 13011 | 0.160 |
Why?
|
| Artifacts | 1 | 2021 | 110 | 0.160 |
Why?
|
| Exosomes | 1 | 2020 | 61 | 0.150 |
Why?
|
| Radiography | 2 | 2012 | 762 | 0.150 |
Why?
|
| Psychiatric Status Rating Scales | 7 | 2018 | 846 | 0.150 |
Why?
|
| Oxygen | 5 | 2018 | 553 | 0.150 |
Why?
|
| Dementia | 2 | 2022 | 435 | 0.150 |
Why?
|
| Depression | 5 | 2024 | 1352 | 0.140 |
Why?
|
| Health Communication | 1 | 2019 | 31 | 0.140 |
Why?
|
| Common Data Elements | 1 | 2018 | 6 | 0.140 |
Why?
|
| Brain Contusion | 1 | 2018 | 2 | 0.140 |
Why?
|
| Memory, Episodic | 2 | 2016 | 29 | 0.140 |
Why?
|
| Sensation Disorders | 1 | 2018 | 24 | 0.140 |
Why?
|
| Comorbidity | 5 | 2025 | 1607 | 0.140 |
Why?
|
| Adolescent Development | 1 | 2018 | 37 | 0.140 |
Why?
|
| Fractures, Bone | 1 | 2020 | 212 | 0.130 |
Why?
|
| Caudate Nucleus | 2 | 2015 | 36 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 2123 | 0.130 |
Why?
|
| Reference Values | 3 | 2008 | 692 | 0.130 |
Why?
|
| Ventral Striatum | 1 | 2016 | 43 | 0.120 |
Why?
|
| Space Perception | 1 | 2016 | 53 | 0.120 |
Why?
|
| Anxiety Disorders | 2 | 2015 | 744 | 0.120 |
Why?
|
| Survivors | 3 | 2023 | 352 | 0.120 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 92 | 0.120 |
Why?
|
| Supervised Machine Learning | 1 | 2016 | 10 | 0.120 |
Why?
|
| Neurons | 1 | 2026 | 1998 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2024 | 1224 | 0.120 |
Why?
|
| Electroencephalography | 1 | 2020 | 875 | 0.110 |
Why?
|
| Activities of Daily Living | 3 | 2024 | 409 | 0.110 |
Why?
|
| War Exposure | 1 | 2015 | 8 | 0.110 |
Why?
|
| Quality of Life | 4 | 2025 | 2116 | 0.110 |
Why?
|
| Perception | 1 | 2016 | 227 | 0.110 |
Why?
|
| Child, Preschool | 12 | 2022 | 15066 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2017 | 366 | 0.110 |
Why?
|
| Sports Medicine | 1 | 2015 | 30 | 0.110 |
Why?
|
| Proof of Concept Study | 2 | 2025 | 39 | 0.110 |
Why?
|
| Communication Disorders | 1 | 2014 | 9 | 0.110 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2015 | 93 | 0.110 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2014 | 2 | 0.110 |
Why?
|
| Speech Perception | 1 | 2014 | 57 | 0.110 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 2308 | 0.110 |
Why?
|
| Psychological Tests | 2 | 2013 | 94 | 0.100 |
Why?
|
| Personality | 1 | 2015 | 114 | 0.100 |
Why?
|
| Injury Severity Score | 3 | 2014 | 235 | 0.100 |
Why?
|
| Intelligence Tests | 3 | 2022 | 63 | 0.100 |
Why?
|
| Functional Neuroimaging | 1 | 2013 | 36 | 0.100 |
Why?
|
| Social Class | 3 | 2022 | 212 | 0.100 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2026 | 107 | 0.100 |
Why?
|
| Explosions | 2 | 2024 | 6 | 0.100 |
Why?
|
| User-Computer Interface | 2 | 2013 | 165 | 0.100 |
Why?
|
| Social Behavior Disorders | 1 | 2013 | 12 | 0.100 |
Why?
|
| Accidents, Traffic | 2 | 2010 | 105 | 0.100 |
Why?
|
| Observer Variation | 2 | 2010 | 319 | 0.100 |
Why?
|
| Bayes Theorem | 2 | 2026 | 307 | 0.100 |
Why?
|
| Self Report | 3 | 2025 | 563 | 0.100 |
Why?
|
| Linear Models | 3 | 2009 | 695 | 0.100 |
Why?
|
| Disability Evaluation | 2 | 2010 | 197 | 0.100 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2012 | 10 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 2 | 2016 | 487 | 0.090 |
Why?
|
| Personality Disorders | 1 | 2015 | 172 | 0.090 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 2 | 2025 | 13 | 0.090 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 153 | 0.090 |
Why?
|
| Sexual Behavior | 1 | 2014 | 244 | 0.090 |
Why?
|
| Intention | 1 | 2013 | 100 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 224 | 0.090 |
Why?
|
| Cognitive Reserve | 1 | 2011 | 5 | 0.090 |
Why?
|
| Affect | 1 | 2013 | 170 | 0.090 |
Why?
|
| Body Temperature | 1 | 2012 | 128 | 0.090 |
Why?
|
| Urban Population | 1 | 2014 | 281 | 0.090 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 120 | 0.090 |
Why?
|
| Diffusion | 2 | 2010 | 59 | 0.090 |
Why?
|
| Resilience, Psychological | 1 | 2013 | 81 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2011 | 83 | 0.090 |
Why?
|
| Brain Edema | 2 | 2009 | 65 | 0.090 |
Why?
|
| Fornix, Brain | 1 | 2010 | 23 | 0.080 |
Why?
|
| Mood Disorders | 3 | 2018 | 132 | 0.080 |
Why?
|
| Thalamus | 2 | 2008 | 88 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 683 | 0.080 |
Why?
|
| Time | 2 | 2010 | 96 | 0.080 |
Why?
|
| Matched-Pair Analysis | 2 | 2008 | 28 | 0.080 |
Why?
|
| Surveys and Questionnaires | 4 | 2018 | 4058 | 0.080 |
Why?
|
| Reaction Time | 2 | 2024 | 158 | 0.080 |
Why?
|
| Facial Expression | 2 | 2013 | 27 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 2148 | 0.080 |
Why?
|
| Warfare | 1 | 2010 | 33 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2010 | 144 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 395 | 0.080 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 135 | 0.080 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17703 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 2088 | 0.080 |
Why?
|
| Automation | 1 | 2010 | 67 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2022 | 1406 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 824 | 0.080 |
Why?
|
| Neuronal Plasticity | 1 | 2012 | 288 | 0.070 |
Why?
|
| Motivation | 1 | 2011 | 332 | 0.070 |
Why?
|
| Mesencephalon | 1 | 2008 | 39 | 0.070 |
Why?
|
| Verbal Behavior | 3 | 2016 | 50 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1215 | 0.070 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2025 | 713 | 0.070 |
Why?
|
| Attention | 3 | 2016 | 198 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 6922 | 0.070 |
Why?
|
| Mental Recall | 2 | 2021 | 142 | 0.070 |
Why?
|
| Prevalence | 4 | 2016 | 2697 | 0.060 |
Why?
|
| Rehabilitation Centers | 1 | 2006 | 27 | 0.060 |
Why?
|
| Canada | 3 | 2013 | 328 | 0.060 |
Why?
|
| Pain Measurement | 2 | 2018 | 356 | 0.060 |
Why?
|
| Decision Making | 1 | 2011 | 687 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 2006 | 84 | 0.060 |
Why?
|
| Neurofilament Proteins | 1 | 2026 | 39 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2006 | 129 | 0.060 |
Why?
|
| Interpersonal Relations | 2 | 2021 | 227 | 0.060 |
Why?
|
| Head | 1 | 2025 | 115 | 0.050 |
Why?
|
| Paraparesis, Spastic | 1 | 2004 | 4 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2005 | 272 | 0.050 |
Why?
|
| Aging, Premature | 1 | 2024 | 32 | 0.050 |
Why?
|
| Propensity Score | 1 | 2025 | 266 | 0.050 |
Why?
|
| Hand Strength | 1 | 2024 | 59 | 0.050 |
Why?
|
| Visual Perception | 1 | 2005 | 130 | 0.050 |
Why?
|
| Central Nervous System Depressants | 1 | 2004 | 22 | 0.050 |
Why?
|
| Deep Brain Stimulation | 1 | 2009 | 449 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2025 | 442 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2004 | 152 | 0.050 |
Why?
|
| Health Status | 1 | 2025 | 388 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2026 | 379 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2017 | 773 | 0.050 |
Why?
|
| Ethanol | 1 | 2004 | 164 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 2009 | 726 | 0.050 |
Why?
|
| Protons | 1 | 2022 | 100 | 0.050 |
Why?
|
| Psychometrics | 1 | 2006 | 678 | 0.050 |
Why?
|
| Trail Making Test | 1 | 2021 | 6 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2024 | 419 | 0.040 |
Why?
|
| Intelligence | 2 | 2015 | 105 | 0.040 |
Why?
|
| Hematoma, Subdural | 1 | 2021 | 28 | 0.040 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2021 | 31 | 0.040 |
Why?
|
| International Classification of Diseases | 1 | 2022 | 97 | 0.040 |
Why?
|
| Disease Progression | 2 | 2018 | 2226 | 0.040 |
Why?
|
| Length of Stay | 1 | 2006 | 1400 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 283 | 0.040 |
Why?
|
| Polysomnography | 1 | 2020 | 155 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2021 | 135 | 0.040 |
Why?
|
| Newspapers as Topic | 1 | 2019 | 6 | 0.040 |
Why?
|
| Preliminary Data | 1 | 2018 | 9 | 0.040 |
Why?
|
| United States Department of Defense | 1 | 2018 | 11 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2026 | 1840 | 0.040 |
Why?
|
| Learning | 1 | 2021 | 374 | 0.030 |
Why?
|
| Psychotherapy | 1 | 2021 | 246 | 0.030 |
Why?
|
| Language | 2 | 2011 | 220 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2018 | 235 | 0.030 |
Why?
|
| Environment | 1 | 2018 | 149 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2009 | 3135 | 0.030 |
Why?
|
| Psychomotor Performance | 2 | 2010 | 178 | 0.030 |
Why?
|
| Psychiatry | 1 | 2020 | 272 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 236 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2004 | 1612 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2018 | 346 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 2016 | 68 | 0.030 |
Why?
|
| Animals | 3 | 2015 | 34460 | 0.030 |
Why?
|
| Sleep Wake Disorders | 1 | 2018 | 204 | 0.030 |
Why?
|
| Life Style | 1 | 2018 | 445 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2016 | 214 | 0.030 |
Why?
|
| Narration | 1 | 2014 | 33 | 0.030 |
Why?
|
| Vocalization, Animal | 1 | 2014 | 20 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1572 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2018 | 782 | 0.030 |
Why?
|
| Anxiety | 1 | 2021 | 1030 | 0.030 |
Why?
|
| Violence | 1 | 2014 | 128 | 0.020 |
Why?
|
| Alkaloids | 1 | 2013 | 36 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 432 | 0.020 |
Why?
|
| Suction | 1 | 2012 | 50 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2011 | 3708 | 0.020 |
Why?
|
| Inpatients | 1 | 2016 | 544 | 0.020 |
Why?
|
| Hospitalization | 1 | 2021 | 1942 | 0.020 |
Why?
|
| Family Health | 1 | 2013 | 251 | 0.020 |
Why?
|
| Craniotomy | 1 | 2012 | 102 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 290 | 0.020 |
Why?
|
| Causality | 1 | 2011 | 92 | 0.020 |
Why?
|
| Intracranial Pressure | 1 | 2012 | 215 | 0.020 |
Why?
|
| Computer Graphics | 1 | 2010 | 41 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 321 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 429 | 0.020 |
Why?
|
| Bone Diseases | 1 | 2011 | 44 | 0.020 |
Why?
|
| Social Perception | 1 | 2011 | 54 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 2010 | 37 | 0.020 |
Why?
|
| Putamen | 1 | 2010 | 25 | 0.020 |
Why?
|
| Internal Capsule | 1 | 2010 | 50 | 0.020 |
Why?
|
| Language Disorders | 1 | 2009 | 25 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2010 | 173 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 744 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2009 | 192 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2009 | 174 | 0.020 |
Why?
|
| Family | 1 | 2012 | 593 | 0.020 |
Why?
|
| Brain Stem | 1 | 2008 | 112 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 1255 | 0.020 |
Why?
|
| Pons | 1 | 2007 | 34 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 570 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2012 | 1345 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 1236 | 0.010 |
Why?
|
| Infant | 2 | 2011 | 13332 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 4762 | 0.010 |
Why?
|
| Software | 1 | 2010 | 756 | 0.010 |
Why?
|
| Michigan | 1 | 2004 | 47 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 2004 | 52 | 0.010 |
Why?
|
| Codon | 1 | 2004 | 95 | 0.010 |
Why?
|
| Texas | 1 | 2013 | 3629 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 410 | 0.010 |
Why?
|
| Age of Onset | 1 | 2004 | 631 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 18504 | 0.010 |
Why?
|